Modeling human neurological disorders with induced pluripotent stem cells.
about
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesMitochondrial targets for pharmacological intervention in human diseaseEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesRNA Sequencing in SchizophreniaHuman pluripotent stem cells on artificial microenvironments: a high content perspectiveLarge-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture SystemAdvances in understanding the cell types and approaches used for generating induced pluripotent stem cells.Connectivity and circuitry in a dish versus in a brainModeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.Urine-derived induced pluripotent stem cells as a modeling tool for paroxysmal kinesigenic dyskinesia.Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease ModelingModeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.iPS cell technologies: significance and applications to CNS regeneration and disease.Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.A Novel Probe as Surface Glycan Marker of Pluripotent Stem Cells: Research Outcomes and Application to Regenerative Medicine.Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling.Three-Dimensional Models of the Human Brain Development and Diseases.Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes.Neurotransmitter release: vacuolar ATPase V0 sector c-subunits in possible gene or cell therapies for Parkinson's, Alzheimer's, and psychiatric diseases.Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.Models for discovery of targeted therapy in genetic epileptic encephalopathies.Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.Use of Human Neurons Derived via Cellular Reprogramming Methods to Study Host-Parasite Interactions of Toxoplasma gondii in Neurons.Type-I interferons in Parkinson's disease: innate inflammatory response drives fate of neurons in model of degenerative brain disorder: An editorial comment on 'Type-I interferons mediate the neuroinflammatory response and neurotoxicity induced by rGenome-Edited, TH-expressing Neuroblastoma Cells as a Disease Model for Dopamine-Related Disorders: A Proof-of-Concept Study on DJ-1-deficient Parkinsonism.Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.Functional Comparison of Neuronal Cells Differentiated from Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Different Oxygen and Medium Conditions.Protein Kinase-A Inhibition Is Sufficient to Support Human Neural Stem Cells Self-Renewal.A switch from canonical to noncanonical Wnt signaling mediates early differentiation of human neural stem cells.Rostrocaudal Areal Patterning of Human PSC-Derived Cortical Neurons by FGF8 Signaling.Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation.Comprehensive comparative analysis of 5'-end RNA-sequencing methodsDerivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata)
P2860
Q26799331-697B283F-37AB-46C3-A240-229B9BB0AAF1Q26824514-02936A2A-6C29-4ABD-92CD-200858227D25Q26850868-413AB82F-CD46-4477-84C0-D48563BBE65FQ26996831-B225209A-FDA7-4D69-988F-C56130F653DFQ28656439-6747C76A-D9EE-4B2C-8A80-C7201E45D6DAQ28829869-8EFA04DD-C6D4-4DFE-B2B0-8CF77ADBF81FQ35653333-34850D1D-952E-41F1-805B-2A92676F27B5Q35684598-42A98F97-9E47-4B72-8FFB-9EB870804958Q36510263-C4FAE218-6BBD-4468-B096-E73A6E64665EQ36529186-288ECC1A-DF5B-4CD7-B48B-12C43148C7FFQ36678789-445BABCB-878E-4266-81AA-19219507E252Q37304493-EC2D0470-226F-4DB1-B52E-09936938A2F0Q37648244-065C39D6-979D-4302-BB04-B9A18DC2B71BQ37688424-73904601-EC65-4D12-AB0B-4B38E9C24B0EQ38242113-6642BC6A-4532-4363-A83B-CB09BB3455FBQ38420482-FDC68C87-EB1B-47FB-8EE3-1EED510C56A7Q38531969-CCC3F060-3A69-4332-89F9-CA3CAFD6ED6CQ38636780-49B41B42-DD65-437D-A4E0-5ECAC8314C25Q38820880-506E4A99-E43C-42E0-84CC-63D819EDC6A6Q38854566-347CC078-6688-4C29-924A-A2DBF04281F8Q38884155-F27CCD81-EA5A-40DE-8F93-74E4922468BDQ38893465-07308E02-91C5-463D-B895-0AD68AB46E1CQ39443289-B2B7CBC2-7370-4465-A5AB-C88546EF850DQ39457643-D7C36853-9B82-44B1-96DE-A9A6107BA689Q40637296-F1AE78E2-11D3-4DD9-88DE-9895255DCB19Q47161722-E4A2A2AE-305C-49E0-8B23-D303F3C36279Q48089290-C6527080-6CD6-46AB-864B-3213D2529DA7Q49409270-44A4367D-B045-4269-BED5-C114594E16EBQ52568381-02A4F778-82D5-479E-9F43-B380EA1EF1BCQ52916380-5DA5AA5C-8A76-46BB-8E1A-A6EF1EFAE3FEQ53369649-8BB0ADE7-6E58-472D-A4BF-590D16F10873Q54332448-4056D43A-C7FB-4025-9F2D-6FB1EAE904FEQ55401574-14EFBAAA-07D9-4B14-ADB4-26E5CB2830D1Q55711095-396DEE93-826A-4542-92BB-6F51D5BD5AE9Q56879461-69B82507-9BD2-4912-951B-E4096E8A393CQ58778293-FCA12C04-939A-4354-A561-41E8AB316387
P2860
Modeling human neurological disorders with induced pluripotent stem cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Modeling human neurological disorders with induced pluripotent stem cells.
@ast
Modeling human neurological disorders with induced pluripotent stem cells.
@en
type
label
Modeling human neurological disorders with induced pluripotent stem cells.
@ast
Modeling human neurological disorders with induced pluripotent stem cells.
@en
prefLabel
Modeling human neurological disorders with induced pluripotent stem cells.
@ast
Modeling human neurological disorders with induced pluripotent stem cells.
@en
P2860
P356
P1476
Modeling human neurological disorders with induced pluripotent stem cells.
@en
P2093
Yoichi Imaizumi
P2860
P304
P356
10.1111/JNC.12625
P407
P577
2013-12-15T00:00:00Z